Feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus activity mediated by a soluble factor(s)

Journal of General Virology

Volumn 79, Issue 11, 1998, Pages 2729-2735

  Hohdatsu, Tsutomu ^a   Okubo, Miki ^a   Koyama, Hiroyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAT; DOWN REGULATION; FELINE IMMUNODEFICIENCY VIRUS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; RNA VIRUSES;

EID: 0031792915     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-11-2729     Document Type: Article

References (40)

1. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. & Berger, E. A. (1996). CC CKR5: a RANTES, MIP-1 α and MIP-1 β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
2. Baier, M., Wermer, A., Bannet, N., Metzner, K. & Kurth, R. (1995). HIV suppression by interleukin-16. Nature 378, 563.
3. Biswas, P., Poli, G., Kinter, A. L., Justement, J. S., Stanley, S. K., Maury, W. J., Bressler, P., Orenstein, J. M. & Fauci, A. S. (1992). Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. Journal of Experimental Medicine 176, 739-750.
4. + cells. Evidence for a soluble inhibitor. Journal of Immunology 144, 2961-2966.
5. + T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Research and Human Retroviruses 9, 1079-1086.
6. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., McKay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. & Sodroski, J. (1996). The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
7. + T cells. Science 270, 1811-1815.
8. Deng, H.-K., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. & Landau, N. R. (1996). Identification of the major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
9. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. & Doms, R. W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
10. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
11. English, R. V., Nelson, P., Johnson, C. M., Nasisse, M., Tompkins, W. A. & Tompkins, M. B. (1994). Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. Journal of Infectious Diseases 170, 543-552.
12. Fauci, A. S. (1993). Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018.
13. Fauci, A. S. (1996). Host factors and the pathogenesis of HIV-induced disease. Nature 384, 529-534.
14. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
15. + T cells correlates with CD4 counts and clinical stage of disease. Clinical and Experimental Immunology 97, 68-75.
16. Greenberg, M. L., Lacey, S. F., Chen, C. H., Bolognesi, D. P. & Weinhold, K. J. (1997). Noncytolytic CD8 T cell-mediated suppression of HIV replication. Springer Seminars in Immunopathology 18, 355-369.
17. Hosie, M. J., Broere, N., Hesselgesser, J., Turner, J. D., Hoxie, J. A., Neil, J. C. & Willett, B. J. (1998). Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. Journal of Virology 72, 2097-2104.
18. + antiviral activity in cats infected with feline immunodeficiency virus. Journal of Virology 70, 2474-2480.
19. Kohmoto, M., Uetsuka, K., Ikeda, Y., Inoshima, Y., Shimojima, M., Sato, E., Inada, G., Toyosaki, T., Miyazawa, T., Doi, K. & Mikami, T. (1998). Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV Petaluma strain. Journal of Veterinary Medical Science 60, 315-321.
20. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology and Immunopathology 69, 106-116.
21. + T cells. Immunology Today 17, 217-224.
22. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Research and Human Retroviruses 6, 1039-1050.
23. + cell anti-HIV activity correlates with the clinical state of the infected individual. Journal of Clinical Investigation 87, 1462-1466.
24. + cell antiviral factor. Cellular Immunology 153, 329-343.
25. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92, 2308-2312.
26. Montaner, L. J., Doyle, A. G., Collin, M., Herbein, G., Illei, P., James, W., Minty, A., Caput, D., Ferrara, P. & Gordon, S. (1993). Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. Journal of Experimental Medicine 178, 743-747.
27. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1 α, and MIP-1 β, suppress HIV-1 replication in monocyte/macrophages. Proceedings of the National Academy of Sciences, USA 93, 15341-15345.
28. Pedersen, N. C., Ho, E. W., Brown, M. L. & Yamamoto, J. K. (1987). Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 790-793.
29. Poli, G. & Fauci, A. S. (1992). The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 60, 246-251.
30. Poli, G. & Fauci, A. S. (1993). Cytokine modulation of HIV expression. Seminars in Immunology 5, 165-173.
31. + T cell-mediated suppression of HIV replication: β-chemokine-dependent and -independent effects. AIDS Research and Human Retroviruses 13, 63-69.
32. + T lymphocytes suppresses HIV replication. Immunology 66, 628-630.
33. Walker, B. D. & Plata, F. (1990). Cytotoxic T lymphocytes against HIV. Journal of Acquired Immune Deficiency Syndromes 4, 177-184.
34. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566.
35. + cells involves a non-cytotoxic mechanism. Journal of Virology 65, 5921-5927.
36. + cells from HIV-1 infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology 137, 420-428.
37. Weissman, D., Poli, G. & Fauci, A. S. (1994). Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Research and Human Retroviruses 10, 1199-1206.
38. Willett, B. J., Picard, L., Hosie, M. J., Turner, J. D., Adema, K. & Clapham, P. R. (1997). Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. Journal of Virology 71, 6407-6415.
39. Yamamoto, J. K., Sparger, E., Ho, E. W., Andersen, P. R., O'Connor, T. P., Mandell, C. P., Lowenstine, L., Munn, R. & Pedersen, N. C. (1988). Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. American Journal of Veterinary Research 49, 1246-1258.
40. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Medicine 3, 659-664.